Stock Evaluator: Oxford Nanopore Technologies plc (OXFYY)
Oxford Nanopore Technologies plc OXFYY
$6.05
0.00
0.00%
July 30, 2026 10:25:44 AM
EST
Volume: 0
After Hours: $120.37
0.15
|
0.12%
November 10, 2021 7:59 PM
EST
Volume: 72,713
USD
| DELAYED PRICE
| SECTOR | INDUSTRY |
| Health Care | Life Sciences Tools & Services |
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
COMPANY SUMMARY
Oxford Nanopore Technologies plc engages in the research, development, manufacture, and commercialization of a novel generation of deoxyribonucleic acid (DNA) or ribonucleic acid (RNA) sequencing technology that allows analysis of DNA or RNA. The company offers MinION Mk 1D, a portable device for DNA and RNA sequencing; and GridION and GridION Q, a compact bench top device that delivers a version of hardware, software, and chemistry. It also provides PromethION products, such as PromethION 2, PromethION 24, and PromethION 48. The company has a collaboration with Cepheid to develop and commercialize automated infectious disease sequencing solutions. It operates in the region of Americas, Europe, the Middle East, Africa, India, and the Asia Pacific. The company was formerly known as Oxford NanoLabs Limited and changed its name to Oxford Nanopore Technologies plc in May 2008. Oxford Nanopore Technologies plc was incorporated in 2005 and is headquartered in Oxford, the United Kingdom.
Financial Summary
| Share Statistics | OXFYY | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $1,487.0 | $1,790.4 | 50% |
|
| Shares Out (Mil) | 1,297.4 | 94.8 | 96% |
|
| Institutional Ownership | 49.9% | 90.0% | 27% |
|
| Float (Mil) | 394.8 | 69.9 | 83% |
|
| Beta | 0.91 | 1.20 | 54% |
|
| Avg Daily Volume (000s) | 1 | 814 | 4% |
|
| Price Change (52-week) |
na | 80.2% | na |
|
| Growth | OXFYY | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | 14.1% | 7.8% | 71% |
|
| Net Income (5yr) | (18.5%) | (13.7%) | 21% |
|
| EPS (5yr) | (11.3%) | 0.7% | 20 |
|
| Dividends (5yr) | 0.0% | 0.0% | 0% |
|
| Cash Flow (5yr) | (17.1%) | (15.0%) | 41% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | na | na | na | |
| Current EPS | na | na | na | |
| Month Ago EPS | na | na | na | |
| # Rev Up | na | na | na | |
| # Rev Down | na | na | na | |
| Three Months Ago EPS | na | na | na | |
| Year/Year Chg | na | na | na | |
| Financials | OXFYY | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $301 | $785 | 36% |
|
| Net Income (TTM) (Mil) | ($195) | ($14) | 7% |
|
| EPS (TTM) | ($0.203) | ($0.200) | 33% |
|
| Operating Cash Flow (TTM) (Mil) | ($95) | $53 | 6% |
|
| Net Cash Flow (TTM) (Mil) | ($25) | ($4) | 25% |
|
| Long-Term Debt (Q1) (Mil) | $49 | $270 | 39% |
|
| Enterprise Value (Q1) (Mil) | $1,238 | $2,444 | 43% |
|
| Valuation | OXFYY | Industry Median |
Percentile (All Stocks) |
|
| P/B | na | 2.92 | na |
|
| P/E | na | 43.7 | na |
|
| Dividend Yield | na | 0.0% | na |
|
| PEG (5yr hist) | na | 5.3 | na |
|
| Ratios | OXFYY | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 60.9% | 47.6% | 73% |
|
| Net Margin | (64.9%) | (2.9%) | 10% |
|
| ROA | (22.1%) | (2.8%) | 20% |
|
| ROE | (28.8%) | (4.5%) | 21% |
|
| Liabilities to Assets | 25.6% | 43.0% | 17% |
|
| F-Score | na | 5 | na |
|
Oxford Nanopore Technologies plc did not pass any screens on 7/31/2026.
